Competition issues in Portugal have gained momentum since a new competition act was passed in June 2003. The act empowers a new supervisory body, the Competition Authority, to tackle, what was until recently, a dormant issue. The recent application of an €16 million fine against five drugs and diagnostics multinationals forms the most striking example of how seriously competition issues are taken in Portugal. The fine is the largest ever and was imposed for concerted practises in 36 different public tenders to supply 22 hospitals. Although the rules are not radically different from those established by the 1993 Competition Act, the Competition Authority has been awarded the statutory independence, and the resources, to pursue a serious and comprehensive competition policy that was previously lacking. Apart from public-sector supplies, the Competition Authority has been showing a steadfast approach to its duties, tackling such different markets and sectors as telecoms, energy, construction and pharmaceuticals.
December 01 2005